Position in ROIV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,294,344
+$5,025,100 QoQ
Shares Held
149,600
+1439.1% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#137
of 494 holders
Holding Since
Dec 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HSBC HOLDINGS PLC holds $1,221,504,678 across 135 Biotechnology names. ROIV ranks #29 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
676,247 | $335,912,169 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
382,028 | $238,209,735 | |
| 3 | INCY |
Incyte Corp
|
1,307,743 | $148,245,744 | |
| 4 | RPRX |
Royalty Pharma plc
|
1,224,925 | $68,681,542 | |
| 5 | MRNA |
Moderna, Inc.
|
636,199 | $44,553,014 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
115,279 | $34,702,435 | |
| 7 | INSM |
INSMED Inc
|
279,961 | $29,849,438 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
307,543 | $17,597,610 |
All Filings in ROIV
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,294,344 | 149,600 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $269,244 | 9,720 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $896,144 | 41,297 | Shares | Defined | 2026-03-06 | |
| 2022-12-31 | $94,553 | 11,834 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $77,898 | 24,192 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $131,733 | 32,367 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $72,538 | 14,684 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $117,996 | 11,706 | Shares | Defined | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||